AstraZeneca's decision to withdraw Vaxzevria reflects the complexities of vaccine development and the importance of transparent communication regarding vaccine safety.... May 13
While acknowledging rare side effect concerns, the data showcases the vaccine's significant benefits in combating COVID-19.... May 08
The legal actions initiated by affected families highlight the need for comprehensive investigations into vaccine-related adverse events and the pursuit of accountability.... May 02
The findings offer valuable insights into the underlying mechanisms of obesity and hold promise for developing novel drugs or optimizing existing treatments for this prevalent ... Apr 05
AI-based diagnostics startup Qure.ai has gained $40 million (Rs 304.5 crores) in its venture round led by Novo Holdings and HealthQuad.... Mar 31
CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Learn how ... Feb 26
Latest Pharma news... Feb 23
Let us know who has reduced the risk of infection after covid vaccination- Elderly V/s Middle-aged group V/s Young children. Let us ... Feb 18
Two weeks after your second COVID19 vaccine dose, the immunity against the virus will be at their peak ... Oct 04
Latest pharma update... Sep 27
In the period between 1988-89, the company only manufactured penicillin. They have since then expanded into antibiotics, anti-allergic, antiretrovirals, cardiovascular, central nervous system ... Sep 21
WHO covid vaccine forecast... Sep 13
Latest Pharma News Update... Sep 03
Different studies are being carried out worldwide to understand if a combination of two different vaccines can outperform two doses of the same vaccines ... Aug 11
Japan helps Bangladesh to fight the pandemic... Jul 26
New solutions are needed for the six million people in the US affected by anaemia of chronic kidney disease.... Jul 17
Mixing vaccines are safe says Germany... Jul 03
If approved, Forxiga has the potential to change the treatment paradigm for millions of people in the EU suffering from chronic kidney disease... Jun 28
... Jun 24
Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
This approval follows a priority review designation by the Center for Drug Evaluation of China’s National Medical Products Administration (NMPA) and marks the first ... Jun 23
First medicine approved in the EU to treat this rare and debilitating genetic condition... Jun 22
The Delta Plus variant may soon grow to evade Covid-19 vaccines and even immunity gained from previous infections, warned Prof Shahid Jameel, a former ... Jun 22
In fewer than twelve months, AstraZeneca has worked extremely hard to develop an effective vaccine at no profit and is the second-largest supplier to ... Jun 18
Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant ... Jun 16
-Advertisements-
Friday, May 17, 2024
.jpg)
